SCHEMBL6175583

SCHEMBL6175583

CCOC(=O)Oc1cc2cc([N+](=O)[O-])ccc2n1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.47
ELANE P08246 1/20 0.45
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
ALOX12 P18054 1/20 0.45
MAPT P10636 5/20 0.44
ALDH1A1 P00352 3/20 0.44
NPC1 O15118 1/20 0.44
NPBWR1 P48145 1/20 0.44
RAB9A P51151 1/20 0.44
MCHR1 Q99705 1/20 0.44
CYP19A1 P11511 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
TP53 P04637 1/20 0.42
NOD2 Q9HC29 1/20 0.41
NOD1 Q9Y239 1/20 0.41
MPI P34949 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4D Q08499 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7517971 0.88 NOD2 (0.52) ARELANEMEN1KMT2AALOX12
SCHEMBL6608082 0.83 MAPT (0.51) ARELANEMEN1KMT2AMAPT
SCHEMBL6019391 0.82 NOD2 (0.55) ARELANEMEN1KMT2AALOX12
SCHEMBL10173095 0.82 MAPT (0.45) ELANEMEN1KMT2AMAPTALDH1A1
SCHEMBL6173410 0.82 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL6172815 0.80 KMT2A (0.49) ELANEMEN1KMT2AMAPTALDH1A1
SCHEMBL6173011 0.78 KMT2A (0.41) ELANEMEN1KMT2AMAPTALDH1A1
SCHEMBL8131642 0.77 MAPT (0.43) ELANEMEN1KMT2AMAPTALDH1A1
SCHEMBL8132926 0.77 ALDH1A1 (0.45) ARELANEMEN1KMT2AMAPT
SCHEMBL7515285 0.75 NOD2 (0.42) MEN1KMT2AMAPTALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432415-B1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2005-12-28 EP disclosed
EP-1432415-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES Bayer HealthCare AG (DE) 2004-06-30 EP disclosed
WO-2003028719-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2003-04-10 WO disclosed